# Quality of Life in Patients With Non-adipocyte Soft Tissue Sarcoma Under Palliative Chemotherapy or Pazopanib

> **NCT03735758** · PHASE4 · TERMINATED · sponsor: **GWT-TUD GmbH** · enrollment: 11 (actual)

## Conditions studied

- Soft Tissue Sarcoma Adult

## Interventions

- **DRUG:** pazopanib or guideline conform chemotherapy

## Key facts

- **NCT ID:** NCT03735758
- **Lead sponsor:** GWT-TUD GmbH
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-11-02
- **Primary completion:** 2020-10-06
- **Final completion:** 2020-10-06
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** problems with recruiting
- **Last updated:** 2021-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03735758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03735758, "Quality of Life in Patients With Non-adipocyte Soft Tissue Sarcoma Under Palliative Chemotherapy or Pazopanib". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03735758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*